Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
This thesis presents a comprehensive study on the development and evaluation of novel drug delivery systems for targeted cancer therapy. Cancer remains a leading cause of mortality worldwide, necessitating the continuous exploration of innovative treatment strategies to improve patient outcomes. Targeted drug delivery systems have emerged as promising approaches to enhance the therapeutic efficacy of anticancer agents while minimizing off-target effects and reducing systemic toxicity. This research focuses on the design, development, and evaluation of novel drug delivery systems tailored for specific cancer types, with a primary emphasis on enhancing treatment precision and efficacy. The introduction provides a detailed overview of the research background, emphasizing the significance of targeted drug delivery systems in cancer therapy. The background of the study explores the current challenges in cancer treatment, highlighting the limitations of conventional chemotherapy and the need for more effective and targeted approaches. The problem statement identifies the gaps in existing drug delivery systems and underscores the importance of developing novel strategies to address these limitations. The objectives of the study are outlined to guide the research process, with a focus on designing innovative drug delivery systems that can selectively target cancer cells while sparing normal tissues. The limitations of the study are acknowledged, including potential challenges in the translation of preclinical findings to clinical applications. The scope of the study delineates the specific aspects of drug delivery system development and evaluation that will be explored in this research. The literature review critically evaluates existing research on targeted drug delivery systems for cancer therapy, highlighting key advancements, challenges, and opportunities for innovation. The research methodology section outlines the experimental approach, including the selection of drug candidates, formulation design, in vitro and in vivo evaluation, and data analysis methods. Various aspects such as formulation optimization, drug release kinetics, cellular uptake mechanisms, and therapeutic efficacy assessments are discussed in detail. The findings of the study are comprehensively discussed in the results and discussion chapter, presenting the outcomes of in vitro and in vivo experiments on novel drug delivery systems. The efficacy, specificity, and safety profiles of the developed formulations are evaluated, providing insights into their potential clinical applications. The conclusion summarizes the key findings of the study, emphasizing the significance of targeted drug delivery systems in improving cancer treatment outcomes. Overall, this thesis contributes to the growing body of knowledge on innovative drug delivery systems for targeted cancer therapy and provides valuable insights into the design, development, and evaluation of novel formulations. The findings of this research have the potential to enhance the efficacy and safety of cancer treatment, ultimately benefiting patients through personalized and precise therapeutic interventions.